Drugs / MEDI8662
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00952705 | Aug 2009 → Jan 2010 | — | MedImmune LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MEDI8662 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00952705 ↗ |
| Known as | Q/LAIV-BFS | “Q/LAIV-BFS (quadrivalent influenza vaccine) (MEDI8662)” NCT00952705 ↗ |
| Modality | Vaccine | “quadrivalent live attenuated influenza vaccine” NCT00952705 ↗ |